Catalent | CTLT - Nettoeinkommen



Nettoeinkommen Veränderung Datum
Agilent USD 305M 129M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Bruker USD 26M 88.4M 2025-12
Centene USD -1.1B 5.53B 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Cigna USD 1.23B 55.22B 2025-12
Danaher USD 1.2B 289M 2025-12
Dentsply International USD -146M 281M 2025-12
Elevance Health USD 547M 642M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Hologic USD 179.1M 8.2M 2025-12
Humana USD -796M 991M 2025-12
Illumina USD 334M 184M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
J&J USD 5.12B 36M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Lonza CHF 307M 22M 2024-12
McKesson USD 1.19B 76M 2025-12
Merck EUR 902M 250M 2025-09
Merck USD 2.96B 2.82B 2025-12
Mettler Toledo International USD 285.76M 68.27M 2025-12
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Quest Diagnostics USD 245M 0 2025-12
Repligen USD 13.29M 1.62M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Thermo Fisher Scientific USD 1.96B 348M 2025-12
UnitedHealth USD 10M 2.34B 2025-12
Veradigm USD 14.53M 78.55M 2022-09
Waters USD 225.21M 76.29M 2025-12
West Pharmaceutical Services USD 132.1M 7.9M 2025-12